Jump to main content
Jump to site search

Issue 90, 2016, Issue in Progress
Previous Article Next Article

Non-competitive inhibitor of nucleoside hydrolase from Leishmania donovani identified by fragment-based drug discovery

Author affiliations

Abstract

Nucleoside hydrolase is an important target for the development of new leishmanicidal agents due to its role in parasite proliferation. Using the principles of fragment-based drug discovery, a library of 111 fragments was assembled for screening by nuclear magnetic resonance using the saturation transfer difference. Five fragments were selected as ligands of Leishmania donovani nucleoside hydrolase (NHLd) and kinetics studies revealed that fragment 3 acts as a new non-competitive inhibitor. Its binding mode was proposed on the basis of molecular docking, using a structural model of NHLd constructed by homology. An intermolecular interaction between fragments 3 and 5 was found by NOESY and docking studies. These data could be used to design more potent NHLd inhibitors and to aid the development of leishmanicidal drugs.

Graphical abstract: Non-competitive inhibitor of nucleoside hydrolase from Leishmania donovani identified by fragment-based drug discovery

Back to tab navigation

Supplementary files

Publication details

The article was received on 10 Jun 2016, accepted on 30 Aug 2016 and first published on 31 Aug 2016


Article type: Paper
DOI: 10.1039/C6RA15143D
Author version
available:
Download author version (PDF)
Citation: RSC Adv., 2016,6, 87738-87744

  •   Request permissions

    Non-competitive inhibitor of nucleoside hydrolase from Leishmania donovani identified by fragment-based drug discovery

    M. A. Alves, C. Nirma, M. M. Moreira, R. O. Soares, P. G. Pascutti, F. Noël, P. R. R. Costa, C. M. R. Sant'Anna, E. J. Barreiro, L. M. Lima and L. W. Tinoco, RSC Adv., 2016, 6, 87738
    DOI: 10.1039/C6RA15143D

Search articles by author

Spotlight

Advertisements